{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T04:05:06Z","timestamp":1771301106709,"version":"3.50.1"},"reference-count":87,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.tmrv.2017.07.002","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T05:04:16Z","timestamp":1499922256000},"page":"236-244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Acute Management of Hemostasis in Patients With Neurological Injury"],"prefix":"10.1016","volume":"31","author":[{"given":"M. Irem","family":"Baharoglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anneke","family":"Brand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria M.","family":"Koopman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marinus","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvo B.W.E.M.","family":"Roos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2017.07.002_bb0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000441085","article-title":"Update on the global burden of ischemic and hemorrhagic stroke in 1990-2013: the GBD 2013 study","volume":"45","author":"Feigin","year":"2015","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0010","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1212\/01.wnl.0000208408.98482.99","article-title":"Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage","volume":"66","author":"Davis","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0015","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/01.STR.23.5.641","article-title":"Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset","volume":"23","author":"Haley","year":"1992","journal-title":"Stroke"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0020","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/01.STR.23.5.632","article-title":"Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes","volume":"23","author":"Brott","year":"1992","journal-title":"Stroke"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0025","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0030","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/jama.1995.03530130023023","article-title":"Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)","volume":"274","author":"Hacke","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0035","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0140-6736(95)92049-8","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM199607183350301","volume":"335","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0045","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/S0140-6736(12)60768-5","article-title":"The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the Third International Stroke Trial [IST-3]): a randomised controlled trial","volume":"379","author":"I.S.T.c. Group","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0050","first-page":"CD000213","article-title":"Thrombolysis for acute ischaemic stroke","author":"Wardlaw","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0055","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(10)60491-6","article-title":"Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials","volume":"375","author":"Lees","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0060","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","article-title":"Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials","volume":"384","author":"Emberson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0065","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(07)60149-4","article-title":"Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST): an observational study","volume":"369","author":"Wahlgren","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0070","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1097\/CCM.0000000000002057","article-title":"Guideline for reversal of Antithrombotics in intracranial hemorrhage: executive summary. A statement for healthcare professionals from the Neurocritical Care Society and the Society of Critical Care Medicine","volume":"44","author":"Frontera","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0075","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(12)60949-0","article-title":"A. Investigators. Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial","volume":"380","author":"Zinkstok","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0080","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1161\/STROKEAHA.112.664003","article-title":"Clinical applications of the computed tomography angiography spot sign in acute intracerebral hemorrhage: a review","volume":"43","author":"Brouwers","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1755-5922.2009.00118.x","article-title":"Systematic review of observational research studying the long-term use of antithrombotic medicines following intracerebral hemorrhage","volume":"28","author":"Flynn","year":"2010","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0090","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/STROKEAHA.113.003003","article-title":"Incidence of oral anticoagulant-associated intracerebral hemorrhage in the Netherlands","volume":"45","author":"Schols","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0095","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1212\/01.WNL.0000138428.40673.83","article-title":"Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage","volume":"63","author":"Flibotte","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0100","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jama.2015.0846","article-title":"Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage","volume":"313","author":"Kuramatsu","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0105","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/archinte.164.8.880","article-title":"The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage","volume":"164","author":"Rosand","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0110","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/01.STR.0000221786.81354.d6","article-title":"Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates","volume":"37","author":"Huttner","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0115","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1747-4949.2012.00926.x","article-title":"Improved survival of patients with warfarin-associated intracerebral haemorrhage: a retrospective longitudinal population-based study","volume":"10","author":"Huhtakangas","year":"2015","journal-title":"Int J Stroke"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0120","first-page":"87","article-title":"Correction of coagulopathy in warfarin associated cerebral hemorrhage","volume":"15","author":"Aiyagari","year":"2009","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0125","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S1474-4422(16)00110-1","article-title":"Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial","volume":"15","author":"Steiner","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0130","first-page":"486","article-title":"The benefit of prothrombin complex concentrate in decreasing neurological deterioration in patients with warfarin-associated intracerebral haemorrhage","volume":"20","author":"Fong","year":"2014","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0135","doi-asserted-by":"crossref","DOI":"10.1111\/1755-5922.12254","article-title":"The Tasmanian atrial fibrillation study: transition to direct oral anticoagulants 2011-2015","author":"Alamneh","year":"2017","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0140","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000455012","article-title":"Changes in oral anticoagulant treatment rates in atrial fibrillation before and after the introduction of direct oral anticoagulants","volume":"47","author":"Shah","year":"2016","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0145","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0150","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0155","first-page":"1486","article-title":"New oral anticoagulants and the risk of intracranial hemorrhage: traditional and Bayesian meta-analysis and mixed treatment comparison of randomized trials of new oral anticoagulants in atrial fibrillation","volume":"70","author":"Chatterjee","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ajem.2016.09.046","article-title":"Bleeding with direct oral anticoagulants vs warfarin: clinical experience","volume":"34","author":"Eikelboom","year":"2016","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0165","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1502000","article-title":"Idarucizumab for dabigatran reversal","volume":"373","author":"Pollack","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0170","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMoa1607887","article-title":"Andexanet alfa for acute major bleeding associated with factor Xa inhibitors","volume":"375","author":"Connolly","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0175","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1161\/CIRCULATIONAHA.111.029017","article-title":"Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects","volume":"124","author":"Eerenberg","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0180","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1160\/TH12-03-0179","article-title":"Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers","volume":"108","author":"Marlu","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0185","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Antithrombotic Trialists","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0190","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1474-4422(07)70107-2","article-title":"Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study","volume":"6","author":"Lovelock","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0195","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1161\/STROKEAHA.109.550939","article-title":"Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage","volume":"40","author":"Naidech","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0200","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(84)91393-X","article-title":"Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders","volume":"1","author":"Kobrinsky","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0205","doi-asserted-by":"crossref","first-page":"298767","DOI":"10.1155\/2014\/298767","article-title":"Desmopressin acetate in intracranial haemorrhage","volume":"2014","author":"Kapapa","year":"2014","journal-title":"Neurol Res Int"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0210","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1161\/STROKEAHA.114.006061","article-title":"Desmopressin improves platelet activity in acute intracerebral hemorrhage","volume":"45","author":"Naidech","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0215","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/jth.13576","article-title":"Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomized controlled trials","volume":"15","author":"Desborough","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0220","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12028-011-9619-3","article-title":"Early platelet transfusion improves platelet activity and may improve outcomes after intracerebral hemorrhage","volume":"16","author":"Naidech","year":"2012","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0225","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1179\/174313209X459129","article-title":"Impact of platelet transfusion on hematoma expansion in patients receiving antiplatelet agents before intracerebral hemorrhage","volume":"32","author":"Ducruet","year":"2010","journal-title":"Neurol Res"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0230","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jstrokecerebrovasdis.2008.10.007","article-title":"Prior antiplatelet therapy, platelet infusion therapy, and outcome after intracerebral hemorrhage","volume":"18","author":"Creutzfeldt","year":"2009","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0235","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5387\/fms.2015-26","article-title":"Intracranial hemorrhage and platelet transfusion after administration of anti-platelets agents: Fukushima prefecture","volume":"62","author":"Suzuki","year":"2016","journal-title":"Fukushima J Med Sci"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0240","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/S0140-6736(16)30392-0","article-title":"Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial","volume":"387","author":"Baharoglu","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0245","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1538-7836.2006.02245.x","article-title":"Normalization of platelet reactivity in clopidogrel-treated subjects","volume":"5","author":"Vilahur","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0250","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1111\/j.1538-7836.2011.04392.x","article-title":"Low platelet reactivity is recovered by transfusion of stored platelets: a healthy volunteer in vivo study","volume":"9","author":"Pruller","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0255","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1538-7836.2012.04641.x","article-title":"Reversal of the anti-platelet effects of aspirin and clopidogrel","volume":"10","author":"Li","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0260","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3171\/2012.9.JNS112286","article-title":"Effect of acetylsalicylic acid usage and platelet transfusion on postoperative hemorrhage and activities of daily living in patients with acute intracerebral hemorrhage","volume":"118","author":"Li","year":"2013","journal-title":"J Neurosurg"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0265","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/(SICI)1096-8652(199810)59:2<110::AID-AJH2>3.0.CO;2-0","article-title":"Progressive expansion of hypertensive intracerebral hemorrhage by coagulopathy","volume":"59","author":"Takahashi","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0270","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3171\/jns.1994.80.1.0051","article-title":"Hematoma enlargement in spontaneous intracerebral hemorrhage","volume":"80","author":"Fujii","year":"1994","journal-title":"J Neurosurg"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0275","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1161\/STROKEAHA.110.609461","article-title":"Serum low-density lipoprotein cholesterol level predicts hematoma growth and clinical outcome after acute intracerebral hemorrhage","volume":"42","author":"Rodriguez-Luna","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0280","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1212\/01.wnl.0000223349.97278.e0","article-title":"Plasma d-dimer predicts poor outcome after acute intracerebral hemorrhage","volume":"67","author":"Delgado","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0285","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa042991","article-title":"Recombinant activated factor VII for acute intracerebral hemorrhage","volume":"352","author":"Mayer","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0290","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa0707534","article-title":"Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage","volume":"358","author":"Mayer","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0295","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/1747493016641960","article-title":"Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: protocol for a randomized, placebo-controlled trial","volume":"11","author":"Sprigg","year":"2016","journal-title":"Int J Stroke"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0300","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1056\/NEJM198408163110703","article-title":"Antifibrinolytic treatment in subarachnoid hemorrhage","volume":"311","author":"Vermeulen","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0305","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1212\/WNL.54.1.77","article-title":"Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR study group","volume":"54","author":"Roos","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0310","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001245.pub2","article-title":"Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage","author":"Baharoglu","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0315","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1745-6215-14-143","article-title":"Ultra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): study protocol for a randomized controlled trial","volume":"14","author":"Germans","year":"2013","journal-title":"Trials"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0320","article-title":"Antiplatelet therapy for aneurysmal subarachnoid haemorrhage","author":"Dorhout Mees","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0325","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1042\/cs0790591","article-title":"Effect of polycations on the function of the isolated perfused rat kidney","volume":"79","author":"Firth","year":"1990","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0330","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","article-title":"Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"43","author":"Connolly","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0335","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1227\/01.NEU.0000232662.86771.A9","article-title":"Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage","volume":"59","author":"Naidech","year":"2006","journal-title":"Neurosurgery"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0340","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1097\/CCM.0b013e31817c1095","article-title":"Complications associated with anemia and blood transfusion in patients with aneurysmal subarachnoid hemorrhage","volume":"36","author":"Kramer","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0345","doi-asserted-by":"crossref","first-page":"e012623","DOI":"10.1136\/bmjopen-2016-012623","article-title":"Aneurysmal SubArachnoid hemorrhage-red blood cell transfusion and outcome (SAHaRA): a pilot randomised controlled trial protocol","volume":"6","author":"English","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0350","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/bmj.39461.643438.25","article-title":"Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients","volume":"336","author":"Perel","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0355","doi-asserted-by":"crossref","first-page":"397","DOI":"10.7326\/0003-4819-146-6-200703200-00004","article-title":"Predicting intracranial traumatic findings on computed tomography in patients with minor head injury: the CHIP prediction rule","volume":"146","author":"Smits","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0360","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1177\/000313480907501115","article-title":"Does platelet administration affect mortality in elderly head-injured patients taking antiplatelet medications?","volume":"75","author":"Downey","year":"2009","journal-title":"Am Surg"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0365","first-page":"785","article-title":"Predictors of mortality in trauma patients with intracranial hemorrhage on preinjury aspirin or clopidogrel","volume":"65","author":"Ivascu","year":"2008","journal-title":"J Trauma"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0370","first-page":"358","article-title":"Platelet transfusion: an unnecessary risk for mild traumatic brain injury patients on antiplatelet therapy","volume":"71","author":"Washington","year":"2011","journal-title":"J Trauma"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0375","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/01.TA.0000151671.35280.8B","article-title":"Effects of antiplatelet agents on outcomes for elderly patients with traumatic intracranial hemorrhage","volume":"58","author":"Ohm","year":"2005","journal-title":"J Trauma"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0380","first-page":"1303","article-title":"The effects of clopidogrel on elderly traumatic brain injured patients","volume":"65","author":"Wong","year":"2008","journal-title":"J Trauma"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0385","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"Shakur","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0390","doi-asserted-by":"crossref","first-page":"d3795","DOI":"10.1136\/bmj.d3795","article-title":"Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH-2 intracranial bleeding study)","volume":"343","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0395","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-227X-13-20","article-title":"Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial","volume":"13","author":"Yutthakasemsunt","year":"2013","journal-title":"BMC Emerg Med"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0400","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1745-6215-13-87","article-title":"CRASH-3\u2014tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial","volume":"13","author":"Dewan","year":"2012","journal-title":"Trials"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0405","first-page":"83","article-title":"Haemoglobin management in acute brain injury","volume":"19","author":"LeRoux","year":"2013","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0410","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1186\/cc7916","article-title":"Anemia and red blood cell transfusion in neurocritical care","volume":"13","author":"Kramer","year":"2009","journal-title":"Crit Care"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0415","article-title":"Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion","volume":"10","author":"Carson","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.tmrv.2017.07.002_bb0420","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1007\/s00586-004-0716-2","article-title":"Tranexamic acid for major spinal surgery","volume":"13","author":"Neilipovitz","year":"2004","journal-title":"Eur Spine J"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0425","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.11.007","article-title":"Tranexamic acid for spontaneous intracerebral hemorrhage: a randomized controlled pilot trial (ISRCTN50867461)","volume":"23","author":"Sprigg","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0430","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","article-title":"Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"44","author":"Jauch","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.tmrv.2017.07.002_bb0435","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/STR.0000000000000069","article-title":"Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"46","author":"Hemphill","year":"2015","journal-title":"Stroke"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796317300469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796317300469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:17:47Z","timestamp":1760138267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796317300469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0887796317300469"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2017.07.002","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute Management of Hemostasis in Patients With Neurological Injury","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2017.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}